The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Fractyl Health Inc (NASDAQ: GUTS) closed at $1.25 in the last session, down -2.34% from day before closing price of $1.28. In other words, the price has decreased by -$2.34 from its previous closing price. On the day, 1.11 million shares were traded. GUTS stock price reached its highest trading level at $1.29 during the session, while it also had its lowest trading level at $1.22.
Ratios:
We take a closer look at GUTS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 15, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On August 28, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $3.60.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 14 ’25 when Royan Ajay bought 17,901 shares for $1.28 per share. The transaction valued at 22,980 led to the insider holds 17,901 shares of the business.
Barnes Kelly Ann bought 31,000 shares of GUTS for $40,210 on Mar 14 ’25. The Director now owns 31,000 shares after completing the transaction at $1.30 per share. On Mar 13 ’25, another insider, SCHULMAN AMY W, who serves as the Director of the company, bought 8,550 shares for $1.17 each. As a result, the insider paid 9,964 and bolstered with 8,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 165242224 and an Enterprise Value of 102288264. For the stock, the TTM Price-to-Sale (P/S) ratio is 8262.00. Its current Enterprise Value per Revenue stands at 6016.957 whereas that against EBITDA is -1.035.
Stock Price History:
The Beta on a monthly basis for GUTS is 2.15, which has changed by -0.5559503 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $3.48, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is 6.39%, while the 200-Day Moving Average is calculated to be -14.86%.
Shares Statistics:
According to the various share statistics, GUTS traded on average about 3.04M shares per day over the past 3-months and 1298430 shares per day over the past 10 days. A total of 132.19M shares are outstanding, with a floating share count of 108.69M. Insiders hold about 17.78% of the company’s shares, while institutions hold 14.50% stake in the company. Shares short for GUTS as of 1760486400 were 6852307 with a Short Ratio of 2.25, compared to 1757894400 on 1692350. Therefore, it implies a Short% of Shares Outstanding of 6852307 and a Short% of Float of 6.0700003.
Earnings Estimates
The market rating of Fractyl Health Inc (GUTS) is currently shaped by the ongoing analysis conducted by 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.14 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$1.3 and -$1.76 for the fiscal current year, implying an average EPS of -$1.49. EPS for the following year is -$1.01, with 5.0 analysts recommending between -$0.62 and -$1.35.
